Yutaka Shio

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report

Yuki Owada‐Ozaki, Satoshi Muto, Hironori Takagi et al. · Journal of Thoracic Oncology · 2018 · 205 citations

Medicine, Molecular Medicine, Oncology +17

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

Hiroyuki Suzuki, Mitsuro Fukuhara, Takumi Yamaura et al. · Journal of Translational Medicine · 2013 · 78 citations · Full text

Medicine, Immunology, Oncology +17

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer

Yuki Ozaki, Satoshi Muto, Hironori Takagi et al. · Cancer Immunology Immunotherapy · 2019 · 44 citations · Full text

Medicine, Immunology, Oncology +17

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study

Mitsuro Fukuhara, Satoshi Muto, Sho Inomata et al. · Cancer Immunology Immunotherapy · 2021 · 43 citations · Full text

Medicine, Oncology, Surgery +17

Prognostic Impact of Hypoxia-Inducible<i>miRNA-210</i>in Patients with Lung Adenocarcinoma

Jun Osugi, Yuka Kimura, Yuki Owada et al. · Journal of Oncology · 2015 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +17